Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Verhoeven, W. M. A.
Veendrik-Meekes, M. J.
Jacobs, G. A. J.
van den Berg, Y. W. M. M.
and
Tuinier, S.
2001.
Citalopram en pacientes retrasados mentales con depresión: una investigation clínica a largo plazo.
European psychiatry (Ed. Española),
Vol. 8,
Issue. 4,
p.
242.
King, Bryan H.
2002.
Psychopharmacology in mental retardation.
Current Opinion in Psychiatry,
Vol. 15,
Issue. 5,
p.
497.
Lemay, Jean-François
Herbert, Anthony R
Dewey, Deborah M
and
Innes, A Micheil
2003.
A rational approach to the child with mental retardation for the paediatrician.
Paediatrics & Child Health,
Vol. 8,
Issue. 6,
p.
345.
Hässler, Frank
2006.
Polypharmazie in der Behandlung psychischer Erkrankungen.
p.
103.
Handen, Benjamin L.
and
Gilchrist, Richard
2006.
Practitioner Review: Psychopharmacology in children and adolescents with mental retardation.
Journal of Child Psychology and Psychiatry,
Vol. 47,
Issue. 9,
p.
871.
Sohanpal, S. K.
Deb, S.
Thomas, C.
Soni, R.
Lenôtre, L.
and
Unwin, G.
2007.
The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review.
Journal of Intellectual Disability Research,
Vol. 51,
Issue. 10,
p.
750.
Ulzen, Thaddeus P.
and
Powers, Richard E.
2008.
A Review of Empirical Evidence of Somatic Treatment Options for the MI/DD Population.
Psychiatric Quarterly,
Vol. 79,
Issue. 3,
p.
265.
Antonacci, Diana J.
and
Attiah, Nadir
2008.
Diagnosis and Treatment of Mood Disorders in Adults with Developmental Disabilities.
Psychiatric Quarterly,
Vol. 79,
Issue. 3,
p.
171.
Matson, Johnny L.
Rivet, Tessa T.
and
Fodstad, Jill C.
2009.
Matson Evaluation of Drug Side-Effects (MEDS) Profiles of Selective Serotonin Reuptake Inhibitors (SSRI) in Adults with Intellectual Disability.
Journal of Developmental and Physical Disabilities,
Vol. 21,
Issue. 1,
p.
57.
Hässler, Frank
2009.
Polypharmazie in der Behandlung psychischer Erkrankungen.
p.
119.
Rai, Prem R.
and
Kerr, Mike
2010.
Antidepressant use in adults with intellectual disability.
The Psychiatrist,
Vol. 34,
Issue. 4,
p.
123.
Palucka, Anna M.
Desarkar, Pushpal
and
Lunsky, Yona
2015.
Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities.
p.
78.
Häβler, Frank
Thome, Johannes
and
Reis, Olaf
2015.
Polypharmacy in the treatment of subjects with intellectual disability.
Journal of Neural Transmission,
Vol. 122,
Issue. S1,
p.
93.
2015.
Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities.
p.
55.
Häßler, Frank
2016.
Polypharmazie in der Behandlung psychischer Erkrankungen.
p.
115.
Ji, Na Young
and
Findling, Robert L.
2016.
Pharmacotherapy for mental health problems in people with intellectual disability.
Current Opinion in Psychiatry,
Vol. 29,
Issue. 2,
p.
103.
Hamers, P. C. M.
Festen, D. A. M.
and
Hermans, H.
2018.
Non‐pharmacological interventions for adults with intellectual disabilities and depression: a systematic review.
Journal of Intellectual Disability Research,
Vol. 62,
Issue. 8,
p.
684.
Kemp, Gail N.
Curren, Laura C.
O’Connor, Erin E.
Kritikos, Tessa K.
and
Tompson, Martha C.
2020.
Handbook of Dual Diagnosis.
p.
455.
Ogundare, Temitope
Onifade, Peter O.
Ogundapo, ‘Deji
Ghebrehiwet, Senait
Borba, Christina P. C.
and
Henderson, David C.
2021.
Relationship between quality of life and social integration among patients with schizophrenia attending a Nigerian tertiary hospital.
Quality of Life Research,
Vol. 30,
Issue. 6,
p.
1665.
Weiss, Margaret Danielle
Daniolos, Peter T.
Coughlin, Kevin
Mulvaney-Day, Norah
Cook, Benjamin
and
Rosenblum, Debra
2024.
A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth.
Journal of Child and Adolescent Psychopharmacology,
Vol. 34,
Issue. 7,
p.
292.
Comments
No Comments have been published for this article.